Levi & Korsinsky announces it has commenced an investigation of Revance
Therapeutics, Inc. (“Revance”) (NASDAQ:RVNC) concerning possible
violations of federal securities laws. The investigation concerns
whether certain statements made in its Registration Statement issued in
connection with its June 19, 2014 follow-on public stock offering were
false and/or misleading and/or omitted material facts. To obtain
additional information go to:
HTTP://ZLK.9NL.COM/REVANCE-THERAPEUTICS-RVNC
or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There
is no cost or obligation to you.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut and Washington D.C. The firm’s attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior results
do not guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150611006387/en/
Copyright Business Wire 2015